In pancreatic cancer, IL-22 promoted pancreatic cancer stemness via IL22RA1/STAT3 signalling, establishing the mechanism of regulation of cancer stemness in the tumour microenvironment [102]. This evidence concerns the gene IL22 and familial pancreatic carcinoma.